Illumina · 4 days ago
Senior Accounting Analyst, SEC Reporting and Technical Accounting (San Diego/Hybrid)
San Diego, CA
Full-time
Hybrid
Mid, Senior Level
$82K/yr - $124K/yr
5+ years expIllumina is a company focused on expanding access to genomic technology to achieve health equity. The Senior Accounting Analyst, SEC Reporting and Technical Accounting will contribute to the preparation of SEC filings and conduct accounting research on complex transactions while ensuring compliance with financial reporting processes.
BiotechnologyGeneticsHealth CareMedical
No H1B
Responsibilities
Assist in the preparation of Forms 10-Q and 10-K, including drafting of disclosures
Support the quarterly earnings press release process
Participate in quarterly reviews and annual audits
Assist with technical accounting research and analysis on non-recurring and complex transactions and document accounting conclusions in a memo
Monitor, assess and contribute to the implementation of new accounting pronouncements applicable to the company, partnering with relevant stakeholders
Ensure maintenance of excellent internal controls over the financial reporting process, including disciplined and high-quality documentation and tie-outs
Stay abreast of SEC and FASB guidance and pronouncements
Work closely with internal and external auditors to support the audit process
Qualification
Required
Bachelor's degree in accounting; Active CPA license required
Typically requires a minimum of 5 years of related experience; Big 4 accounting firm experience preferred
Understanding of U.S. GAAP and SEC reporting regulations required
Strong analytical, communication and technical writing skills
Ability to work independently and demonstrate initiative in a fast paced environment
Ability to effectively set priorities and manage multiple tasks and deadlines
Proficiency with Microsoft Excel, Word and PowerPoint are required
Preferred
Big 4 accounting firm experience preferred
Working knowledge of Workiva and experience with XBRL tagging is a plus
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Steven Barnard
Chief Technology Officer, Head of Research & Product Development
Jenny Lei Zheng
SVP & GM of Greater China
Recent News
2026-01-09
2026-01-09
2026-01-09
Company data provided by crunchbase